NasdaqCM - Nasdaq Real Time Price USD

Virpax Pharmaceuticals, Inc. (VRPX)

Compare
0.3530 -0.0470 (-11.75%)
At close: 4:00:00 PM EST
0.3441 -0.01 (-2.52%)
After hours: 6:17:49 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -2.01M
Q4'23
Q1'24
Q2'24
Q3'24
-4M
-3M
-2M
-1M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

3.00
3.00 Average
0.3530 Current
3.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
No. of Analysts 1--11
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) 0.00%--0.00%0.00%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -3---1.53-0.54
EPS Actual -12.06-2.75-1.75-0.43
Difference -9.06---0.220.11
Surprise % -302.00%---14.38%20.37%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
VRPX --------
S&P 500 5.00%12.00%2.10%12.20%

Upgrades & Downgrades

Downgrade Maxim Group: Buy to Hold 10/9/2024
Upgrade Maxim Group: Hold to Buy 7/19/2024
Downgrade Maxim Group: Buy to Hold 5/22/2024

Related Tickers